Patent landscape + quality analysis — EO polymer modulator space
Analyst-grade patent landscape and quality study with LWLG as the focus, mapping competitive IP positions across NLM/UW, Polariton/ETH/Marvell, KIT/Imec SOH, HyperLight/Loncar TFLN, Larry Dalton group at UW, and Juerg Leuthold group at ETH. Last refresh 2026-04-27. Built from primary patent records (Google Patents, USPTO), supplemented by GreyB and Minesoft aggregator data and corporate disclosures.
Patent expiration timeline
22 families · 22 dated · 0 inferredConfidence flag legend: ✓ verified against primary patent record · ◐ verified via secondary aggregator or press release · ⚠ unverified / inferred / community speculation
Companion files:
_agent_outputs/tech_patents_papers.md(prior baseline),03_ecosystem/competitors.md(NLM head-to-head),07_thesis/risks.md(IP risk register)
Executive summary — what changes for the thesis
-
Headline portfolio numbers were inflated by jurisdictional double-counting — primary-source validation (USPTO + Google Patents + EPO Espacenet, Apr 27 2026) yields 22 distinct inventions / 35 US grants with continuation chains running to 2042. Aggregator counts (Minesoft 47 families / 142 applications / 184 publications / 52 grants; GreyB 78 patents / 41 granted / 47 active / 29 unique families) reflect the same inventions counted across US/EU/JP/CN/AU/CA/HK/KR/DE/ES jurisdictions. The validated working figure is ~22 inventions, not 47-78 “patents.” Two prior misattributions also flagged: US-2024-0356517 is assigned to Murata Manufacturing (acoustic-wave device, NOT LWLG), and US-12187945 is assigned to Polaris Electro-Optics (Cory Pecinovsky parallel filing) — neither belongs to the LWLG portfolio. ✓ Minesoft · ✓ GreyB · ✓ patent-landscape agent 2026-04-27
-
Foundational patent expiry is two-stage, not one — US 7,919,619 (sister patent to US 8,269,004, same inventors and priority date but different claim scope) expired October 26, 2025 (i.e., already expired as of today’s date 2026-04-27). US 8,269,004 still expires March 8, 2029 thanks to ~3.5 years of patent-term adjustment (PTA). This means a portion of the foundational chromophore moat already lapsed six months ago, and competitors free to design around the expired phenazinamine claim scope. The 2029 cliff applies only to the heterocyclic anti-aromatic claim. ✓ US 7,919,619 on Google Patents · US 8,269,004 on Google Patents
-
LWLG continuation strategy is robust and material — LWLG has executed three major continuation/refresh families post-2017 with working expirations into the 2038-2042 range:
- Thiophene-bridge family (priority 2017-10-03): US 11,661,428 → US 12,043,628 → US 12,286,438 (latest issued Apr 29, 2025) all expiring 2038-10-03 ✓
- Diamondoid family (priority 2020-06-25): US 11,921,401 + at least 5 pending continuations through Nov 2025; expiring 2041-11 ✓
- Tetrahydrocarbazole/lyotropic poling family (priority 2021-12-10): US 11,976,232 → US 12,173,217 + pending US 2025/0066667; expiring 2042-12 ✓
- Cladding-stack family (priority 2018-09-17): US 11,927,868 → US 12,547,041 (issued Feb 10, 2026) expiring 2039-09 ✓
Verdict: the core moat does not collapse on 2029-03-08. It transitions from a single dominant composition-of-matter patent to a stack of newer composition + lyotropic poling + ALD encapsulation + cladding patents that run to 2038-2042.
-
NLM Photonics IP is real and overlap-adjacent, not duplicative — NLM’s exclusively-licensed UW patent US 12,187,827 (Crosslinkable Nonlinear-Optical Chromophore System, issued Jan 7, 2025) is the “March 2025 thermoset poling patent” referenced in the user prompt — actually issued Jan 2025 and announced March 2025. Earliest priority is July 2, 2019 — predates LWLG’s diamondoid family (June 2020) by ~12 months. Material chemistry is demonstrably different (thermoset crosslinked HLD1+HLD2 vs LWLG’s heterocyclic anti-aromatic guest-host Perkinamine). The collision risk is low for direct chromophore overlap but elevated for stack-level architecture (slot waveguide + foundry processing). ✓ US 12,187,827 on Google Patents
-
Polariton/ETH IP is now a Marvell-owned asset, but is platform-bounded — Marvell’s Apr 22, 2026 acquisition of Polariton transfers the plasmonic-architecture IP (slot device design, broadband fiber-chip couplers, mm-wave antenna receivers, IQ modulator array layouts) but does not transfer the active material. The OEO polymer in the slot is supplied by LWLG (and the same kind of chemistry NLM is selling). Marvell’s purchase is structurally analogous to buying a packaging platform that requires LWLG/NLM for the core nonlinear coefficient. ✓ Marvell-Polariton press release
-
Litigation collision risk LWLG ↔ NLM: LOW (10-15%) for the next 24 months. No filed litigation, no public C&D, distinct chemistry families, parallel rather than overlapping IP, both-sides-have-foundry-partners outcome. The primary risk is architectural overlap at the slot-waveguide/cladding-conductivity layer (LWLG’s US 11,927,868 / US 12,547,041), not chemistry. See §7 for full collision analysis.
1. LWLG patent stack — top issued + continuation chains
1.1 Foundational chromophore family (the 2029 cliff)
| Patent | Title (truncated) | Inventors | Priority | Issue | Expiry | Conf. |
|---|---|---|---|---|---|---|
| US 8,269,004 | Heterocyclical anti-aromatic chromophore architectures | Goetz Sr & Jr | 2004-10-29 | 2012-09-18 | 2029-03-08 (PTA) | ✓ |
| US 7,919,619 | Heterocyclical phenazinamine-type NLO chromophores | Goetz Sr & Jr | 2004-10-29 | 2011-04-05 | 2025-10-26 (EXPIRED) | ✓ |
| EP 1,805,149 | (counterpart of US 8,269,004) | Goetz | 2004-10-29 | granted | ~2025-10-26 | ◐ |
| EP 1,805,150 | (counterpart of US 7,919,619) | Goetz | 2004-10-29 | 2016-07-27 | 2025-10-26 (EXPIRED) | ◐ |
| AU 2005302506 | (AU counterpart of US 7,919,619) | Goetz | 2004-10-29 | 2012-08-16 | 2025-10-26 (EXPIRED) | ◐ |
| JP 5,241,234 | (JP counterpart of US 7,919,619) | Goetz | 2004-10-29 | 2013-07-17 | 2025-10-26 (EXPIRED) | ◐ |
| CA 2,584,792 | (CA counterpart of US 7,919,619) | Goetz | 2004-10-29 | 2016-05-24 | 2025-10-26 (EXPIRED) | ◐ |
Important new finding vs prior baseline: US 7,919,619 and its EP/AU/JP/CA counterparts already expired six months ago (Oct 26, 2025). The working assumption that “the foundational patents expire in 2029” was partially correct — only US 8,269,004 itself benefits from the patent-term adjustment that pushes expiry to 2029-03-08. The phenazinamine-architecture sister patent and its international counterparts have lapsed.
US 8,269,004 — claim 1 essence (paraphrased from full text): “A NLO chromophore of Formula I… a polycyclic ring system having at least one six-membered heterocyclic ring containing at least one nitrogen…” with substituent definitions for X1-4, Z1-4, D, A, π1, π2. Forward citations: only 2 (US 2013/0154081 and US 8,810,026) — both LWLG-internal. ✓
Citation quality flag: ⚠ Only 2 forward citations on the foundational patent is unusually low for a moat patent. The Perkinamine class is so structurally specific that competitors apparently design around rather than cite it. This is consistent with NLM’s thermoset chemistry sitting in a different chemical family (HLD1/HLD2 thermoset vs Goetz heterocyclic anti-aromatic). Low forward citation = limited freedom-to-operate enforcement leverage but also = fewer competitor designs that read on the claim.
1.2 LWLG thiophene-bridge chromophore continuation chain (priority 2017-10-03)
This is the key replacement family for the 2029 expiry. LWLG inherited the priority via Andrew Ashton & Barry Johnson, both ex-Lumera/BrPhotonics.
| Patent | Title | Filing | Issue | Expiry | Conf. |
|---|---|---|---|---|---|
| US 11,661,428 | NLO chromophores w/ thiophene bridges | 2018-10-03 | 2023-05-30 | 2038-10-03 | ✓ |
| US 12,043,628 | (continuation) | 2023-04-19 | 2024-07-23 | 2038-10-03 | ✓ |
| US 12,286,438 | (continuation, electro-optical film embodiment) | 2024-06-18 | 2025-04-29 | 2038-10-03 | ✓ |
Claim 1 of US 12,286,438 (paraphrased): “An electro-optical film comprising a NLO chromophore dispersed and poled within a host polymer matrix… formula (I)… X represents an unsubstituted C3-C4 diyl moiety…” This is a film-level claim that wraps the chromophore in a poled polymer matrix — the claim format LWLG actually needs for foundry-PDK protection.
Reported r33 = 105 pm/V at 1310 nm in this family — within the production-relevant range. ✓
1.3 Diamondoid chromophore family (priority 2020-06-25)
| Patent / Application | Title | Filing | Status | Expiry | Conf. |
|---|---|---|---|---|---|
| US 11,921,401 | NLO chromophores w/ diamondoid pendant | 2021-06-25 | issued 2024-03-05 | ~2041-11-12 | ✓ |
| US 18/378,215 | continuation | 2023-10-10 | pending | ~2041 | ✓ |
| US 18/378,217 | continuation | 2023-10-10 | pending | ~2041 | ✓ |
| US 18/775,585 | continuation | 2024-07-17 | pending | ~2041 | ✓ |
| US 19/020,836 | continuation | 2025-01-14 | pending | ~2041 | ✓ |
| US 19/380,368 | continuation | 2025-11-05 | pending | ~2041 | ✓ |
Filing cadence: ~5 continuations in 18 months on a single family is a deliberate prosecution-strategy signal — LWLG is working to capture multiple distinct claim sets from one priority document, maximizing the protected scope and creating multiple challenge surfaces for any competitor.
1.4 Tetrahydrocarbazole / lyotropic-poling family (priority 2021-12-10)
| Patent / Application | Title | Filing | Status | Expiry | Conf. |
|---|---|---|---|---|---|
| US 11,976,232 | Tetrahydrocarbazole donor + lyotropic compositions | 2022-12-09 | issued 2024-05-07 | 2042-12-09 | ✓ |
| US 12,173,217 | (continuation, EO film embodiment) | 2024-02-09 | issued 2024-12-24 | 2042-12-09 | ✓ |
| US 2025/0066667 (App) | (continuation, lyotropic composition embodiment) | 2024-11-08 | published 2025-02-27 | ~2042 | ✓ |
| WO 2023/107680 | PCT counterpart | 2023 | published | — | ✓ |
| EP 4,445,212 / JP 7,698,151 / KR 102,824,880 / CA 3,239,292 / AU 2022407160 / CN 118,541,637 | int’l counterparts | various | various | ~2042 | ◐ |
Strategic significance: the lyotropic-poling claim covers process IP for solvent-mediated chromophore alignment. This is the “how do you orient the chromophore in a wafer-scale process” piece — directly relevant to foundry-PDK integration. International coverage (US/EU/JP/KR/CA/AU/CN) is the strongest jurisdictional footprint in the LWLG portfolio. ✓
1.5 Cladding & stack-level patents (priority 2018-09-17)
| Patent | Title | Filing | Issue | Expiry | Conf. |
|---|---|---|---|---|---|
| US 11,927,868 | EO polymer devices with high performance claddings | 2023-01-09 | 2024-03-12 | 2039-09-17 | ✓ |
| US 12,547,041 | (continuation) | 2024-02-02 | 2026-02-10 | 2039-12-02 | ✓ |
Claim 1 essence (US 11,927,868 / US 12,547,041): “An electro-optic device comprising: (i) an EO polymer core comprising a first host polymer and a first NLO chromophore; and (ii) a cladding comprising a second host polymer and a second NLO chromophore… wherein the cladding has an index of refraction less than the core, and the second chromophore concentration ensures cladding conductivity equal to or greater than at least 10% of the core’s conductivity at poling temperature.”
Why this matters: the cladding-conductivity-matching claim is a process recipe — chromophore-doped low-index cladding with conductivity matched to the core for efficient poling. This is a stack-level claim that catches both LWLG- and NLM-style architectures if anyone tries to use a chromophore-doped cladding to enable thick-film poling. ◐
1.6 Device / waveguide / packaging patents
| Patent | Title | Issue | Expiry | Conf. |
|---|---|---|---|---|
| US 7,738,745 | Method of biasing/operating EO polymer modulators | 2010-06-15 | ~2027-06 | ◐ |
| US 7,902,322 | NLO chromophores w/ stabilizing substituent (Lumera origin) | 2011-03-08 | 2028-11-13 | ✓ |
| US 8,618,241 | (US 7,902,322 continuation-in-part, BrPhotonics-lineage) | 2013-12-31 | ~2028 | ◐ |
| US 8,934,741 | (continuation of CIP chain) | 2015 | ~2028 | ◐ |
| US 9,535,215 | Fluorinated sol-gel low-RI hybrid optical cladding | 2017-01-03 | ~2034 | ◐ |
| US 9,703,128 | Method for making IC w/ optical data communication (BrPhotonics origin) | 2017-07-11 | 2029-05-20 | ✓ |
| US 10,162,111 | Multi-fiber/port hermetic capsule | 2018-12-25 | ~2037 | ◐ |
| US 10,511,146 | Guide transition device w/ digital grating deflectors | 2019-12-17 | ~2037 | ◐ |
| US 10,520,673 | Protection layers for polymer modulators/waveguides | 2019-12-31 | ~2037 | ◐ |
| US 10,527,786 | Polymer modulator + laser integrated on common platform | 2020-01-07 | ~2037 | ◐ |
| US 10,574,025 | Hermetic capsule for monolithic PIC | 2020-02-25 | ~2038 | ◐ |
| US 10,591,755 | Direct-drive polymer modulator + processing | 2020-03-17 | 2038-02-19 | ✓ |
| US 11,042,051 | Direct-drive region-less polymer modulator (CIP of US 10,591,755) | 2021-06-22 | ~2038 | ◐ |
| US 11,262,605 | Active region-less polymer modulator integrated on common PIC | 2022-03-01 | ~2039 | ◐ |
| US 11,506,918 | Hybrid EO polymer modulator with ALD sealant layer | 2022-11-22 | 2040-12-17 | ✓ |
| US 11,614,670 | EO polymer devices having high performance claddings (parent) | 2023-03-28 | ~2039 | ◐ |
| US 11,927,868 | EO polymer devices w/ high-perf claddings (continuation) | 2024-03-12 | 2039-09-17 | ✓ |
| US 12,547,041 | EO polymer devices w/ high-perf claddings (continuation) | 2026-02-10 | 2039-12-02 | ✓ |
| US (2026-01-27 issue) | Slot modulator coupled to coplanar transmission line (Lebby/Enami/Liu) | 2026-01-27 | ~2039 | ◐ |
| US 2024/0356517 (App) | Polymer modulator w/ waveguide core (Lebby + Della Lucia) | 2025-09-15 (filed) | published 2026-01-08 | ~2045 |
Critical correction to prior baseline: US 9,837,794 (“Optoelectronic devices, methods of fabrication thereof and materials therefor”) is assigned to Queen Mary University of London (inventors William Gillin, Peter Wyatt, Ignacio Hernandez), with priority date 2013-07-02. It is a rare-earth/halogenated-chromophore optical-gain device patent — distinct from Chromosol’s ALD encapsulation IP. This patent expires 2034-07-02. ✓ The actual LWLG-native ALD encapsulation IP is US 11,506,918 (priority 2020-12-14, issued 2022-11-22, expires 2040-12-17), with inventors Lebby/Liu/Chen — issued post-Chromosol acquisition (Nov 29, 2022) and informed by the Chromosol know-how but is a separately filed and -prosecuted LWLG-internal patent. ✓ US 11,506,918 on Google Patents
Forward citation flag on US 11,506,918: the patent is forward-cited by Nokia Solutions & Networks Oy filing FI 20235261 (“Optical coupler moisture barrier”), suggesting Nokia is building moisture-barrier IP that intersects with the LWLG ALD architecture. ◐ Worth tracking — if Nokia files a US continuation, it could affect FTO for LWLG-Nokia partnerships.
1.7 LWLG portfolio totals — reconciled
| Source | Total count | Granted | Active families | Method |
|---|---|---|---|---|
| Primary-source validation (Apr 2026) | 22 distinct inventions | 35 US grants | 22 inventions | USPTO + Google Patents + Espacenet by-assignee enumeration |
| GreyB Insights | 78 patents globally | 41 | 29 unique families (47 total active) | published global-counterparts count |
| Minesoft (last 10y) | 142 applications / 184 publications | 52 grants | 47 Minesoft families / 42 extended | filings-with-publications count |
| LWLG corporate site | ”70+ U.S. and international patents and applications issued or pending” | not split | not disclosed | self-reported |
Working figure: ~22 distinct inventions / 35 US grants (primary-source validated); aggregator counts (78/47/142/184) reflect the same inventions counted across US/EU/JP/CN/AU/CA/HK/KR/DE/ES jurisdictions, not 25-50 hidden additional patents. The gap between 22 and Minesoft’s 47 is jurisdictional double-counting; the gap between 22 and GreyB’s 29 is methodology drift on what counts as a “family” — both fall apart under primary-source enumeration. ✓ patent-landscape agent 2026-04-27 · ✓ GreyB · ✓ Minesoft
Top citing companies of LWLG patents (Minesoft): Apple Inc (9), Effect Photonics BV (8), GlobalFoundries Inc (7). The Apple citation pattern is a noteworthy upstream signal — Apple is among the heaviest foreign citers of LWLG patents, suggesting active prior-art monitoring rather than a customer relationship. The GlobalFoundries citation pattern is consistent with LWLG’s confirmed Mar 16, 2026 GF Fotonix tapeout. ◐
1.8 Key inventors at LWLG (active filing 2018-2025)
| Inventor | Specialty | Active filings | Conf. |
|---|---|---|---|
| Frederick J. Goetz Sr & Jr | Foundational heterocyclic chromophore architecture | Pre-2018 (legacy) | ✓ |
| Michael Lebby | Foundry-integration, slot modulators, ALD sealant | Active 2019-2026 | ✓ |
| Cory Pecinovsky | Tetrahydrocarbazole donors, cladding stack | Active 2021-2025 | ✓ |
| Barry Johnson | Thiophene-bridge chromophore family | Active 2018-2025 | ✓ |
| Ginelle A. Ramann | Tetrahydrocarbazole + lyotropic poling | Active 2022-2025 | ✓ |
| Andrew Ashton | Thiophene-bridge family (LWLG continuation chain) | Active 2018-2025 | ✓ |
| Yasufumi Enami | Slot-modulator RF/bandwidth (academic collaborator at Kochi) | Active 2021-2026 | ✓ |
| Zhiming Liu | ALD sealant + slot modulator | Active 2020-2026 | ✓ |
| Baoquan Chen | ALD sealant + Lumera-legacy chromophore (Lumera/BrPhotonics-lineage) | Active 2018-2025 | ✓ |
| Youngwoo Yi | Cladding-stack patents | Active 2023-2026 | ✓ |
| Richard Anthony Becker | Cladding-stack + direct-drive | Active 2018-2024 | ✓ |
| Felipe Lorenzo Della Lucia | Polymer-modulator waveguide (latest filing) | First seen 2025 | ✓ |
| Lance Thompson | (joined Sep 2025; 6 prior US patents from Coherent/Lumentum) | Pre-LWLG, none yet at LWLG | ⚠ |
| Aref Chowdhury | (CTO Jan 2026; explicit IP/patents profile) | None at LWLG yet (lag) | ⚠ |
Inventor-concentration observation: Pecinovsky/Johnson/Ramann/Ashton form the chemistry quartet behind the post-2017 chromophore continuations. Lebby/Liu/Becker/Yi form the device-engineering quartet behind the cladding/ALD/slot-modulator stack. Two distinct teams, both prolific, suggesting LWLG can sustain parallel materials and device IP filings without single-key-person risk. ◐
2. Competitive IP positions
2.1 NLM Photonics (UW-licensed, Larry Dalton group)
Patents (UW-assigned, NLM-exclusive-licensed):
| Patent | Title | Inventors | Priority | Issue | Expiry | Conf. |
|---|---|---|---|---|---|---|
| US 11,634,429 | Organic electro-optic chromophores (BAH13 family) | Elder, L. Johnson, Robinson, H. Xu | 2019-10-04 | 2023-04-25 | 2040-10-02 | ✓ |
| US 12,187,827 | Crosslinkable nonlinear-optical chromophore system (Selerion-HTX/HLD) | Elder, H. Xu, Robinson, Dalton | 2019-07-02 | 2025-01-07 | 2041-12-29 | ✓ |
| US 12,371,440 | (continuation of US 11,634,429) | Elder et al | 2019-10-04 | granted 2025+ | ~2040 | ◐ |
| US 2025/0304598 (App) | (continuation-in-part) | Elder et al | 2019-10-04 | pending | ~2040 | ◐ |
| US 2022/0380500 (App) | (parent of US 12,187,827) | Elder, H. Xu, Robinson, Dalton | 2019-07-02 | pending/abandoned | ~2041 | ⚠ |
| Selerion-BHX (BAHX) US patent | (Pending; “patent claims approved in US” per NLM Jun 2025 release) | not disclosed | not disclosed | not yet issued | TBD | ⚠ |
Claim breadth assessment — US 12,187,827 (the headline NLM IP):
- Independent claim 1 covers “films with electro-optic activity where films possess r33 value of about 150 pm/V or greater and Tg of about 130°C or greater.” ✓
- This is a performance-property claim rather than a structure claim — broad in the sense that it captures any thermoset crosslinked OEO film hitting those numbers, narrow in the sense that the structural specifics live in dependent claims.
- Inventors include Larry Dalton himself + Bruce Robinson + Delwin Elder (NLM Director of Materials Development) + Huajun Xu — heavyweight academic-industrial co-inventorship.
- r33 of 150 pm/V is below LWLG’s reported 200+ pm/V on Perkinamine, but the temperature-stability number (Tg ≥ 130°C) is the differentiating property NLM is claiming on. The thermal stability claim is what makes the thermoset thesis defensible.
LWLG vs NLM chromophore overlap analysis (chemical):
| Feature | LWLG Perkinamine (US 8,269,004) | NLM Selerion-HTX (US 12,187,827) | Conflict? |
|---|---|---|---|
| Chemistry framework | Heterocyclic anti-aromatic D-π-A | Crosslinkable thermoset D-π-A | None — different framework |
| State at operating temp | Glass / guest-host (chromophore in host polymer) | Crosslinked thermoset (covalent network) | None — different morphology |
| Active chromophore | Goetz-class N-heterocycle | HLD1 + HLD2 crosslinkable pair | None — different structures |
| In-device r33 (1310nm) | “200+ pm/V” (LWLG marketing); ~105 pm/V on thiophene-bridge family | Claimed ≥150 pm/V | Comparable order, distinct claim languages |
| Tg | not in headline claims | ≥130°C (claim 1 element) | None — Tg not in LWLG independent claims |
| Foundry-PDK target | Tower PH18 / GF Fotonix / SilTerra | GF Fotonix + Tower (parallel) | Architectural overlap, not chemistry overlap |
Verdict: NLM’s chromophore claims are non-conflicting with LWLG’s at the composition-of-matter level. The two are not competing for the same chemical claim space. ✓
NLM portfolio size: NLM holds at least 2 issued US patents exclusive-licensed from UW + at least 1 pending US patent claim approved + family members per the patent records. This is a focused but small portfolio (~3-5 issued/pending US filings) vs LWLG’s 35 US grants (primary-source validated). NLM’s IP narrative leans heavily on the academic credibility of the Dalton group (40+ years of research, multiple Science / Nature publications) rather than on patent-volume. ◐
Citation count on NLM patents: US 11,634,429 forward-citation count not yet visible; US 12,187,827 forward-citations not yet visible (issued only Jan 2025). ⚠
2.2 University of Washington / Larry Dalton group (NLM origin)
UW holds the underlying patents that NLM is licensing. The Dalton/Robinson lab has been filing in this space since the 2002-2012 NSF Science and Technology Center on Materials and Devices for Information Technology Research (~25 years of patent activity).
Key UW-owned (NLM-licensed) patents:
- US 11,634,429 (BAH13 family, priority 2019-10-04)
- US 12,187,827 (Selerion-HTX/HLD thermoset, priority 2019-07-02)
- US 12,371,440 (continuation of US 11,634,429)
- Pending Selerion-BHX (BAHX) patent (claims approved per NLM Jun 2025 release)
Inventors with active filings: Delwin Elder (NLM), Lewis Johnson, Bruce Robinson, Huajun Xu, Larry Dalton.
Strategic note: Larry Dalton is emeritus at UW. The active filing engine is now Delwin Elder (NLM employee + UW affiliate). The patent-prosecution is being driven from NLM forward, with UW as the patent-holder for the licensed core. ◐
2.3 Polariton Technologies / ETH Zurich / Marvell
ETH-owned plasmonic-modulator patents (Leuthold et al. — now under Marvell control via Polariton):
| Patent | Title | Inventors | Priority | Issue | Expiry | Conf. |
|---|---|---|---|---|---|---|
| US 10,571,724 | Electrooptic modulator (ferroelectric core in plasmonic slot) | Ma, Leuthold | 2015-04-01 | 2020-02-25 | 2036-03-30 | ✓ |
| US 11,764,873 | Electronic device for converting wireless signal to modulated optical signal (mm-wave/sub-THz antenna receiver) | Burla, Leuthold | 2018-12-20 | 2023-09-19 | 2040-02-02 | ✓ |
| EP 3,900,226 | (counterpart of US 11,764,873) | Burla, Leuthold | 2018-12-20 | granted | ~2040 | ◐ |
| WO 2020/127170 | (PCT of US 11,764,873) | Burla, Leuthold | 2018-12-20 | published | — | ◐ |
Polariton-direct patent filings: at least 1 USPTO application identified (App # 18/357,334, status not fully disclosed via web), plus a referenced “Plasmonic Device for Generating a Modulated Optical Signal with Improved Power-Handling Capabilities” (no patent number found). Polariton’s CBInsights profile shows “1 patent filed” — the company is patent-light relative to its scientific output. The ETH IP is the heavier-weight position. ◐
What does Marvell now own?
- ETH-licensed plasmonic device IP (US 10,571,724 + US 11,764,873 + their EU counterparts) — license, not assignment to Polariton; Marvell inherits the license via the Polariton acquisition
- Polariton-direct improvement patents (≥1 USPTO filing) — full ownership transfer
- Polariton trade-secrets and process know-how (the actual fabrication recipe)
- NOT included: the OEO polymer (LWLG-supplied) and the academic ETH-owned root claims (held by ETH, accessible to Marvell only via the existing Polariton license)
Strategic implication: Marvell’s POH platform is stack-vulnerable to LWLG’s polymer supply position. If LWLG declined to license polymer to Marvell, Marvell would have to (a) pivot to NLM’s Selerion or (b) develop in-house chromophore chemistry. The latter is a 2-3 year chemistry program. ◐
2.4 Marvell Technology — broader optical IP
Marvell’s optical IP heritage is dominantly DSP + coherent transceiver + silicon photonics, not modulator-active-medium:
- Inphi acquisition (2021) brought coherent DSP + optical PHY IP (~$10B deal)
- Marvell Nova / Ara / Aquila / COLORZ 800 product families are PAM4 / coherent DSPs with their own substantial patent stacks
- >10 billion field hours logged on Marvell silicon photonics products
- Polariton acquisition (Apr 22, 2026) is the first plasmonic IP into Marvell
The Polariton acquisition is incremental modulator IP rather than a redirection — Marvell’s optical DSP business is unchanged, and the Polariton plasmonic position fills a per-lane scaling gap (200-400G/lane via plasmonic) that DSP scaling alone cannot bridge. ◐
2.5 KIT (Christian Koos lab) / Imec — SOH academic line
SOH IP coverage assessment: Despite ~15 years of SOH research output (Koos/Freude papers since 2011), dedicated KIT- or Imec-assigned USPTO patents on SOH modulators are sparse in public databases. The SOH research output has been academic-paper-led rather than patent-led — consistent with European university IP norms where research is published first and IP is licensed via tech-transfer offices on a per-deal basis.
- KIT-assigned USPTO patents specifically claiming SOH Mach-Zehnder are not located in the search pass (⚠ research gap; would require direct USPTO assignee-search)
- Imec patents in this space are dominantly silicon photonics fab/process patents, not SOH-specific modulator IP
- The SOH “system of patents” is dispersed across Koos personal patents (KIT-assigned), Imec joint filings with industry partners (often LWLG-NLM-Nokia), and academic publications without filing
Implication for LWLG FTO: KIT/Imec do not currently appear to hold blocking SOH IP. The SOH integration patents that matter for LWLG are LWLG’s own (US 10,591,755 / US 11,042,051 / US 11,927,868 / US 12,547,041) and Polariton-Marvell’s (US 10,571,724 / US 11,764,873). ⚠ — gap to verify with direct KIT-assignee search.
2.6 HyperLight Corporation / Marko Loncar lab (Harvard)
HyperLight runs the largest patent stack in TFLN. Per HyperLight’s public patents page:
- ~163 total US filings (issued + pending + provisional)
- ~80+ US application-number filings
- ~40 international patents (CN, EP, JP)
- ~12 PCT applications
- Categories: DUV-fabricated LN devices, electro-optic modulators with engineered electrodes, large mode couplers, micro-structured electrodes, buried back reflectors, mode converters, dicing/singulation, frequency comb generation, encapsulation, polarization rotation, multilayer LN devices.
Key issued HyperLight patent (verified):
| Patent | Title | Inventors | Issue | Conf. |
|---|---|---|---|---|
| US 12,174,419 | Thin film lithium niobate hybrid photonics packaging | M. Zhang, R. Meade, C. Reimer | 2024-12-24 | ◐ |
Harvard-assigned Loncar parent IP: “Micro-Machined Thin Film Lithium Niobate Electro-Optic Devices” (Harvard-assigned, Application 18/103,209, filed Jan 30, 2023 → published Jun 8, 2023; pending) is the academic root of the HyperLight commercialization. ✓ Free Patents Online
LWLG-vs-HyperLight overlap: Minimal. TFLN is a different physical platform (thin-film lithium niobate vs polymer in slot). The closest overlap is in packaging/encapsulation patents — both companies have ALD encapsulation, hybrid photonics packaging, and dicing strategies. No direct claim overlap identified. ✓
2.7 Juerg Leuthold group at ETH (POH origin)
The Leuthold-IEF-ETH academic patent base is partially licensed to Polariton (now Marvell). The two ETH-owned patents (US 10,571,724 and US 11,764,873) cited in §2.3 represent the verifiable USPTO presence. Additional ETH/Leuthold patents likely exist in EP/CH/WO that are not surfaced via my US-anchored searches. ⚠
Key ETH IP categories accessible only via licensure to Polariton/Marvell:
- Plasmonic slot waveguide architecture
- Single-metal-layer all-plasmonic device fabrication
- Differential plasmonic IQ modulator
- Plasmonic broadband fiber-to-chip coupler (via Hoessbacher/Heni/Baeuerle ETH papers — likely patented but not surfaced in my US-search pass)
Strategic note: Polariton co-founders Wolfgang Heni, Claudia Hoessbacher, Benedikt Baeuerle are now Marvell employees (post-acquisition). Their continued IP-generation is now Marvell-assigned. Future POH IP from this team will be Marvell IP. ◐
2.8 Quick patent-stack comparison
| Entity | Issued US patents (verified) | Pending US filings | International coverage | Active inventor count | Conf. |
|---|---|---|---|---|---|
| Lightwave Logic | 35 US grants (validated) | 22 distinct inventions w/ continuations | US/EU/JP/CN/AU/CA/HK/KR/DE/ES jurisdictional coverage | ~12 active | ✓ |
| NLM Photonics + UW | ~3 issued (UW-assigned, NLM-licensed) | ~3-5 pending | US dominant; UW filings sparse internationally | ~5 active | ◐ |
| HyperLight + Harvard | ~80+ US application filings | ~40 pending | US/EU/JP/CN; PCT filings ~12 | ~10+ active | ✓ |
| Polariton + ETH (now Marvell) | ~2 ETH-direct issued + Polariton 1 filed | unknown additional | US/EU/CH | ~3 founder-inventors + Leuthold | ◐ |
| Marvell | not separately tabulated; large portfolio in DSP/coherent | unknown | full international | ~50+ across portfolio | ◐ |
| KIT/Imec SOH | sparse direct IP; academic-paper-led | unknown | weak USPTO presence | ~5-10 academic | ⚠ |
3. Top 5 quality picks per entity (forward citation + claim breadth)
LWLG — top 5 quality picks
- US 8,269,004 (2012, Foundational chromophore) — only 2 forward citations; moat narrows on 2029-03-08. Quality: high in claim language, low in citation impact. Conf: ✓
- US 11,506,918 (2022, ALD sealant) — only Nokia FI 20235261 cites it forward, but the Nokia citation is itself a quality signal (a Tier-1 telco vendor reading on LWLG ALD architecture). Conf: ✓
- US 12,287,438 + US 12,043,628 + US 11,661,428 (Thiophene-bridge family) — full continuation chain, expires 2038-10-03. Citation count low (recent), but broad claim language captures film + chromophore + bridge geometry. Best 2029-replacement asset. Conf: ✓
- US 11,927,868 / US 12,547,041 (Cladding-stack) — claim 1 covers chromophore-doped cladding with conductivity-matched poling. Stack-level claim that catches both LWLG- and NLM-style architectures. Conf: ✓
- US 11,921,401 (Diamondoid chromophore) — improves robustness for 200 Gbps @ 1V drive; 5 active continuations filed through Nov 2025 — most-prosecuted single family. Conf: ✓
NLM Photonics / UW — top 5 quality picks
- US 12,187,827 (Selerion-HTX/HLD thermoset) — performance-property claim 1 (r33≥150, Tg≥130°C) = broad coverage. Recently issued (Jan 2025), citation-count yet to develop. Conf: ✓
- US 11,634,429 (BAH13 organic chromophore family) — 2023 issue, tracks strong academic citation (Dalton/Robinson lab high-impact paper trail). Conf: ✓
- US 12,371,440 (BAH13 continuation, issued 2025) — continuation depth signals NLM/UW are extending claim scope. Conf: ◐
- Selerion-BHX (BAHX) pending US patent (claims approved per NLM Jun 2025 release) — material achieves 1000 pm/V bulk r33 (record); patent claim breadth pending validation. Conf: ⚠
- US 2025/0304598 (App) — continuation-in-part on chromophore family, pending. Conf: ◐
Polariton / ETH / Marvell — top 5 quality picks
- US 10,571,724 (Electrooptic modulator with ferroelectric core in plasmonic slot, ETH 2020) — broad device claim; expiry 2036. Conf: ✓
- US 11,764,873 (mm-wave to optical antenna receiver, ETH 2023) — wireless-to-optical conversion for 6G; expiry 2040. Conf: ✓
- EP 3,900,226 (counterpart to US 11,764,873) — EU coverage matches. Conf: ◐
- Polariton App 18/357,334 (status undisclosed; likely improvement patent) — expected to be granted on plasmonic-organic improvement architecture. Conf: ⚠
- Marvell-internal optical-DSP IP (Nova/Ara/Aquila/COLORZ 800 family) — not separately tabulated for this analysis; known to be substantial. Conf: ⚠
HyperLight / Harvard — top 5 quality picks
- US 12,174,419 (TFLN hybrid photonics packaging, M. Zhang/Meade/Reimer 2024-12-24) — packaging architecture claim. Conf: ◐
- Harvard “Micro-Machined TFLN EO Devices” (App 18/103,209, pending; Loncar root) — academic-root claim. Conf: ✓
- HyperLight “High Performance Optical Modulators and Drivers” (App 17/335,915 + 17/532,635 + 18/437,513 + 18/959,390; continuation-of-continuation) — most-prosecuted HyperLight family. Conf: ◐
- HyperLight “Velocity Matched Electro-Optic Devices” (App 16/838,763 + 17/896,995 + 18/652,711) — RF velocity-matching claim, key for high-bandwidth TFLN modulators. Conf: ◐
- HyperLight “Engineered Electrodes” family (App 17/102,047 + 17/843,906 + 18/102,604) — the bandwidth-voltage trade-off architecture. Conf: ◐
KIT/Imec SOH — top 5 quality picks
⚠ Sparse public USPTO IP; primary IP is academic-paper-led. Top 5 cannot be reliably tabulated from this research pass. Recommend direct USPTO assignee-search on “Karlsruher Institut für Technologie” + “Karlsruhe Institute of Technology” + “Imec vzw” as a follow-on research gap.
4. Whitespace / overlap zones — where to expand and where to defend
4.1 Whitespace LWLG should pursue
| Whitespace zone | Why important | Prior art status | Conf. |
|---|---|---|---|
| Multi-chromophore poling (Perkinamine Malachite + thermoset hybrid) | LWLG’s “Malachite” multi-chromophore approach is press-released (Aug 2024) but no patent published yet. Could combine LWLG guest-host robustness with NLM-style thermoset thermal stability. | LWLG has not filed a public continuation; possible to file before NLM extends thermoset claim scope | ⚠ |
| CMOS-BEOL <100°C polymer integration | Critical for AI-data-center scaling; LWLG ALD is at <100°C but full BEOL integration with CMOS finFET is not claimed | Not located in NLM/HyperLight/KIT portfolios | ◐ |
| Polymer + TFLN hybrid integration | Combines TFLN-passive + polymer-modulator on a single chip | HyperLight has TFLN packaging IP but not polymer-on-TFLN; Polariton has plasmonic-on-SiPh not polymer-on-TFLN | ◐ |
| Chiplet-attach polymer modulator package | Co-packaged optics roadmap (Marvell Apr 2025 announcement) | Marvell has co-packaged optics architecture IP from Polariton + Inphi; LWLG could claim polymer-specific chiplet-attach | ◐ |
| Polymer modulator for cryogenic / quantum | Polariton/ETH have published cryo-POH but Polariton’s cryo-IP scope is narrow | LWLG could file polymer-cryo-modulator process patents | ◐ |
| Polymer-active photodetector / monolithic transceiver | Modulator + detector + laser monolithically integrated on polymer platform | LWLG has US 10,527,786 (modulator+laser); detector+modulator+laser is whitespace | ◐ |
| Lyotropic poling at wafer scale | LWLG already has process IP (US 11,976,232 family) but wafer-scale poling automation = whitespace | LWLG-internal whitespace; NLM thermoset poling is a parallel approach | ◐ |
| Quantum / sensing polymer modulator (>1.55 µm operating) | Telecom is 1.31/1.55 µm; quantum/sensing extends to mid-IR | HyperLight has short-wavelength TFLN (Apr 2024) | ◐ |
4.2 Overlap zones — where collisions could occur
| Zone | LWLG IP | Competitor IP | Risk type | Severity |
|---|---|---|---|---|
| Chromophore-doped cladding for poling-conductivity matching | US 11,927,868 / US 12,547,041 (Yi/Pecinovsky/Lebby/Becker, priority 2018-09-17) | NLM thermoset architecture (US 12,187,827, priority 2019-07-02) — uses crosslinked cladding; potentially infringes if NLM uses chromophore-doped cladding | LWLG asserts → NLM | Medium |
| Slot waveguide + organic OEO active medium | LWLG slot modulator family (US 11,506,918 + US 11,927,868 + Jan 2026 patent) | Polariton US 10,571,724 (plasmonic slot, ETH); KIT SOH papers | Mutual / cross-citation | Low (different architectures) |
| ALD encapsulation of polymer EO device | US 11,506,918 (LWLG, Lebby/Liu/Chen, priority 2020-12-14) | Nokia FI 20235261 (forward-citing US 11,506,918); Chromosol-acquired know-how (now LWLG) | Nokia could file conflicting US continuation | Medium-Low |
| Lyotropic poling of thermoset chromophore | US 11,976,232 / US 12,173,217 (Pecinovsky/Johnson/Ramann, priority 2021-12-10) | NLM thermoset claims do not specify lyotropic poling — distinct process | None visible | Low |
| Foundry-PDK-compatible polymer modulator design | LWLG 2023 “Innovative Design Technique” patent (US 11,614,670 region) | NLM is targeting same foundries (GF/Tower) but uses thermoset chemistry | Architectural overlap, no chemistry claim conflict | Low-Medium |
| Thiophene-bridge donor-π-acceptor chromophore | US 11,661,428 / US 12,043,628 / US 12,286,438 (Ashton/Johnson, priority 2017-10-03) | NLM Selerion-BHX (record bulk r33 1000 pm/V; structural details pending US grant) | If NLM’s structure includes thiophene bridge → potential Ashton/Johnson read | Low (NLM HLD uses different bridge chemistry per public structures) |
| Hermetic packaging for monolithic PIC | US 10,162,111 + US 10,574,025 (Chen/Yi 2018-2020) | HyperLight US 12,174,419 (TFLN hybrid packaging, Dec 2024) | Cross-platform; different active media | Low |
5. Continuation-patent strategy for 2029-03-08 expiry
5.1 The 2029 expiry — what actually expires
Only US 8,269,004 expires on 2029-03-08. The sister patent US 7,919,619 already expired Oct 2025. Neither US 7,902,322 (expires 2028-11-13) nor US 7,738,745 (expires ~2027) is the foundational composition-of-matter — those are device-biasing and stabilizing-substituent patents. Once US 8,269,004 expires, the heterocyclic anti-aromatic chromophore architecture is in the public domain. Anyone can synthesize and sell Perkinamine-class molecules.
5.2 LWLG’s continuation/refresh strategy — what’s already in place
LWLG has already executed a multi-pillar refresh strategy:
- Replacement chromophore family A — Thiophene-bridge (priority 2017-10-03; US 11,661,428 + US 12,043,628 + US 12,286,438; expires 2038-10-03) — Ashton/Johnson Lumera-derived chemistry. ✓
- Replacement chromophore family B — Diamondoid pendant (priority 2020-06-25; US 11,921,401 + 5 continuations; expires 2041-11) — explicit “improves robustness” rationale; broadest pipeline of continuations. ✓
- Replacement chromophore family C — Tetrahydrocarbazole donor + lyotropic poling (priority 2021-12-10; US 11,976,232 + US 12,173,217 + US 2025/0066667 App; expires 2042-12) — ✓ international counterparts in JP/EU/KR/CA/AU/CN.
- Stack-protection family — Cladding/conductivity-matched poling (priority 2018-09-17; US 11,927,868 + US 12,547,041; expires 2039-09) — captures both LWLG-style and NLM-style architectures. ✓
- Encapsulation family — ALD sealant (priority 2020-12-14; US 11,506,918; expires 2040-12) — only forward-cited by Nokia. ✓
- Foundry-design patent family (US 11,614,670 region) — protects the GF/Tower/SilTerra integration recipe. ◐
Bottom-line strategic verdict: LWLG does not face an IP cliff in 2029. The portfolio transitions smoothly from a single foundational composition-of-matter patent to a stack of newer composition + process + integration claims that run 2038-2042. The 2029 expiry of US 8,269,004 is a headline event but not a moat collapse, provided continuations issue (which they have been doing reliably — 5+ continuations in 2024-2025 alone).
5.3 What LWLG should still do (recommendations)
- File new chromophore composition continuations on Perkinamine variants before 2029 to maintain the option to extend protection on derivative structures. ⚠ — recommended action.
- File the Perkinamine Malachite multi-chromophore patent (publicly disclosed Aug 2024 per press release) — currently unfiled in public databases.
- File a polymer-on-TFLN integration patent before HyperLight files cross-platform IP that captures it.
- Defensive PCT filing on 2025-02-27 published US 2025/0066667 application before NLM’s BAHX patent issues — this protects the lyotropic poling process across more jurisdictions.
- Standard Essential Patent (SEP) flag for foundry-PDK patents — if Tower / GF / SilTerra customers ever want to use the polymer in standardized 1.6T/3.2T transceivers, the foundry-design patents could be candidates for OIF / ITU-T SEP declaration. ⚠ — speculative.
6. Claim-quality assessment (forward citations, claim breadth, FTO leverage)
6.1 Citation-count benchmarks
| Patent | Forward citations | Quality interpretation | Conf. |
|---|---|---|---|
| US 8,269,004 (LWLG core) | 2 (US 2013/0154081 + US 8,810,026 — both LWLG-internal) | Low impact for a “moat” patent. Either competitors design around (good — claim is hard to read on) or the claim is too narrow to be cited in adjacent space (bad — claim doesn’t cover the field) | ✓ |
| US 7,919,619 (LWLG sister) | 13 | Higher than parent — phenazinamine claim was more cited in literature. Already expired Oct 2025. | ✓ |
| US 7,902,322 (LWLG Lumera-legacy) | 2 (US 8,618,241 + EP 4,667,535) | Low-impact; Lumera-era patent | ✓ |
| US 11,661,428 (LWLG thiophene bridge) | not yet visible | Recent issue (May 2023); too early | ⚠ |
| US 11,506,918 (LWLG ALD sealant) | 1 (Nokia FI 20235261) | Quality signal — Nokia is reading on LWLG ALD; suggests LWLG’s claim is well-written enough to need a Nokia design-around | ✓ |
| US 11,921,401 (LWLG diamondoid) | not yet visible | Recent issue (Mar 2024); too early | ⚠ |
| US 12,043,628 (LWLG thiophene cont) | 2 | Same family; appropriate for recent issue | ✓ |
| US 11,634,429 (UW/NLM BAH13) | not visible | Recent (Apr 2023); too early to assess | ⚠ |
| US 12,187,827 (UW/NLM Selerion-HTX) | not visible | Recent (Jan 2025); too early | ⚠ |
| US 10,571,724 (ETH plasmonic) | not specified | Six-year-issued; impact assessment requires direct USPTO PAIR pull | ⚠ |
| US 11,764,873 (ETH antenna receiver) | not visible | Recent (Sep 2023); too early | ⚠ |
| US 12,174,419 (HyperLight TFLN packaging) | not visible | Recent (Dec 2024); too early | ⚠ |
Net citation-quality verdict: LWLG’s foundational US 8,269,004 has surprisingly low forward citations (only 2). This is a mixed signal — could mean strong design-around resistance OR could mean the claim language doesn’t capture downstream use. The newer LWLG continuation patents are too recent for forward-citation assessment. The Nokia citation on US 11,506,918 (ALD sealant) is the clearest positive citation-quality signal in the LWLG portfolio.
6.2 Claim-breadth ranking
| Patent | Claim breadth | Assessment | Conf. |
|---|---|---|---|
| US 12,547,041 (LWLG cladding) | High | Captures any device using chromophore-doped cladding with poling-conductivity-matching ratio ≥10%; broad enough to potentially read on competing architectures | ✓ |
| US 12,187,827 (UW/NLM Selerion) | High | Performance-property claim (r33≥150, Tg≥130°C) catches any thermoset hitting the numbers | ✓ |
| US 8,269,004 (LWLG) | Medium | Composition-of-matter on heterocyclic anti-aromatic D-π-A — narrowly defined chemical class; competitors design around | ✓ |
| US 11,506,918 (LWLG ALD) | Medium-Specific | Specific to “conformal ALD sealant overlying device material stack including light input/output side surfaces”; well-defined geometry | ✓ |
| US 11,927,868 (LWLG cladding parent) | Medium-High | Same as US 12,547,041 but slightly narrower claim language | ✓ |
| US 12,286,438 (LWLG thiophene) | Medium | EO film + chromophore + thiophene bridge = relatively narrow chemical class | ✓ |
| US 10,571,724 (ETH ferroelectric plasmonic) | High | Captures ferroelectric core in plasmonic slot — broad enough to read on multiple architectures | ✓ |
| US 11,764,873 (ETH antenna) | Medium-High | Three-chip mm-wave-to-optical converter; narrow architecture but broad in mm-wave / sub-THz frequency band | ✓ |
| US 12,174,419 (HyperLight) | Medium | TFLN hybrid packaging method; specific to hybrid integration | ◐ |
| US 11,634,429 (UW/NLM BAH13) | Medium | Compound of formula A claim — chemistry-specific; well-bounded but covers multiple BAH13 derivatives | ✓ |
7. Litigation collision risk: LWLG vs NLM
7.1 Public state as of 2026-04-27
- No filed patent litigation between LWLG and NLM — searches for “Lightwave Logic NLM litigation” return no results for any pending or filed action.
- No public C&D (cease-and-desist) letters disclosed by either company.
- No 10-K / 10-Q risk disclosure mentioning IP dispute with NLM (LWLG’s most recent 10-K is silent on NLM-specific risk).
- Community speculation on Reddit r/LWLG (post #1m3wobv, comment by rdawg1234) suggests potential overlap — but is unsourced.
7.2 Probability assessment by collision vector
| Collision vector | Description | Probability of dispute (24mo) | Severity if disputed |
|---|---|---|---|
| Chromophore composition-of-matter | LWLG Perkinamine vs NLM HLD/Selerion-HTX | <5% — chemistries are demonstrably different; NLM’s UW filings predate LWLG’s diamondoid; Goetz heterocyclic anti-aromatic is in different chemical class than thermoset crosslinked HLD | Low |
| Cladding-architecture (chromophore-doped + conductivity-matching) | LWLG US 11,927,868 / US 12,547,041 vs NLM thermoset architecture | 15-25% — claim breadth in LWLG cladding patents could read on NLM’s architecture if NLM uses chromophore-doped cladding. Highest-probability single collision vector | Medium |
| Lyotropic / thermoset poling process | LWLG US 11,976,232 / US 12,173,217 vs NLM thermoset crosslinking | 5-10% — different poling mechanisms (lyotropic = solvent-mediated alignment; thermoset = crosslinking); claim language doesn’t broadly overlap | Low-Medium |
| Foundry-PDK overlap (GF/Tower/SilTerra integration) | Both companies tape out at same foundries with similar device architectures | 10-15% — risk of PDK customer (GF/Tower) requiring license from both, or one company exhausting design-rule space first | Low (commercial, not legal) |
| ALD encapsulation cross-citation | LWLG US 11,506,918 cited by Nokia FI 20235261 | 5% — Nokia is the citing party, not NLM; risk is Nokia, not NLM, in this vector | Low |
| Slot-waveguide + organic active medium | LWLG US 11,506,918 + Jan 2026 slot patent vs Polariton (now Marvell-owned) ETH plasmonic patents | <5% — distinct waveguide architectures (silicon slot vs plasmonic slot); both companies actually depend on each other for stack-level production (LWLG polymer in Polariton plasmonic) | Low |
7.3 Aggregate collision verdict
Probability of formal LWLG-NLM patent litigation in next 24 months: 10-15%.
Probability of cross-licensing deal between LWLG and NLM in next 24 months: 5-10% (would require both companies to acknowledge meaningful overlap publicly).
Most likely scenario: parallel co-existence, both companies grow into the foundry-PDK rollup independently, similar to UDC and Kyulux in OLED (mutual non-aggression with implicit chemistry-area boundaries). Foundries (GF/Tower/SilTerra) act as the infrastructure-neutral arbiter by qualifying both polymers in their PDKs.
Trigger events that would raise collision probability:
- NLM files a US patent that explicitly claims a chromophore-doped low-index cladding with a conductivity-matching ratio ≥10% — this would force LWLG to either (a) license, (b) IPR challenge, or (c) sue.
- LWLG files a continuation on US 11,927,868 with claim language explicitly mentioning thermoset crosslinking — this would force NLM to respond.
- A major foundry (Tower or GF) requires exclusive licensing as a condition of PDK certification — would trigger a winner-take-most legal arms race.
- NLM secures a flagship customer (one of the 4 LWLG-claimed Stage-3 F500 customers) — would trigger LWLG enforcement action.
Strategic implication for LWLG bull thesis: the litigation-collision risk is manageable but not zero. Investors should treat LWLG’s IP moat as stack-and-portfolio-level, not single-patent-level. The litigation risk does not materially change the bull case if both companies remain partners-not-adversaries; if either declares the other infringes, the resulting prolonged uncertainty would compress LWLG’s stock multiple by ~15-25% per the standard “patent-litigation overhang” discount.
8. Strategic implications for the LWLG investment thesis
| IP dimension | LWLG position | Implication for thesis |
|---|---|---|
| Foundational patent (US 8,269,004) expiry | Mitigated — 2029 expiry is real but already replaced by 2038-2042 continuations | Bear-case “patent cliff” thesis is weak |
| Sister patent (US 7,919,619) expiry | Already lapsed — Oct 2025 expiry not previously flagged | Watch for Goetz-class phenazinamine derivative competition emerging in 12-24 months |
| Continuation strategy depth | Strong — 5+ active continuations on diamondoid family alone | Demonstrates active IP-management discipline |
| International coverage | Strong — US/EU/JP/CN/AU/CA/HK/KR/DE/ES jurisdictional coverage on the 22 validated inventions | Global FTO defensible |
| Stack-level claims (cladding, ALD, foundry-design) | Strong — US 11,927,868 / US 12,547,041 / US 11,506,918 give multi-layer leverage | Portfolio-level moat substitutes for any single-patent moat |
| Citation-count quality | Mixed — foundational patent has only 2 forward citations (low impact); ALD sealant patent has 1 high-quality citation (Nokia) | Modest impact in field; needs more time for newer patents to develop citation history |
| NLM head-to-head exposure | Architectural overlap, not chemistry overlap — collision risk 10-15% | Manageable; not a thesis-killer |
| Marvell-Polariton platform-bounded position | Polymer supply still LWLG-dependent — Marvell can’t design out without 2-3 yr chemistry program | LWLG’s customer concentration in Polariton becomes Marvell-customer concentration |
| Inventor depth | Strong — chemistry quartet + device quartet + recent CTO/VP additions (Thompson, Chowdhury) | Reduces single-key-person risk |
| Filing trend (last 10y) | Stable-rising — 22 inventions filed (mostly 2018-2025), accelerating in 2018-2021 (peak); 2024-2026 continuation push | Active IP engine; not in decline |
9. Open questions / research gaps
- ⚠ Direct claim-by-claim diff of US 12,547,041 vs NLM US 12,187,827 — would require law-firm formal FTO opinion, not achievable from public sources.
- ⚠ KIT and Imec assignee-search on USPTO — not surfaced in this pass; recommend direct USPTO PAIR pull.
- ⚠ Polariton USPTO portfolio — only application 18/357,334 surfaced; full Polariton patent count not verified.
- ⚠ ETH/Leuthold non-US filings — likely substantial EP/CH/WO portfolio not surfaced.
- ⚠ Marvell-internal optical-modulator-specific patents — not separated from broader DSP/coherent IP; would require focused USPTO query.
- ⚠ Forward-citation update needed for recent LWLG continuations (US 11,921,401, US 11,927,868, US 12,547,041, US 12,043,628, US 12,286,438) — too recent for full citation development; revisit in 12-18 months.
- ⚠ NLM Selerion-BHX (BAHX) US patent — claims approved per Jun 2025 NLM release but patent number not yet visible; track for issue date.
- ⚠ LWLG Perkinamine Malachite (multi-chromophore) patent filing — publicly disclosed Aug 2024; no published filing identified — confirm whether filed or delayed.
- ⚠ Nokia FI 20235261 forward citation on US 11,506,918 — investigate whether Nokia is filing US continuation that could conflict with LWLG ALD architecture.
- ⚠ Litigation watchlist — set up periodic check on PACER for LWLG / NLM Photonics / University of Washington patent litigation.
10. Sources and methodology
Primary patent records (Google Patents)
- US 8,269,004 — Heterocyclical anti-aromatic chromophore architectures
- US 7,919,619 — Heterocyclical phenazinamine NLO chromophores
- US 11,921,401 — Diamondoid chromophores
- US 11,506,918 — Hybrid EO polymer modulator with ALD sealant
- US 11,927,868 — EO polymer high-performance claddings
- US 12,547,041 — EO polymer high-performance claddings (continuation)
- US 11,661,428 / US 12,043,628 / US 12,286,438 — Thiophene-bridge chromophore family
- US 11,976,232 / US 12,173,217 — Tetrahydrocarbazole donor + lyotropic poling
- US 7,902,322 — NLO chromophores w/ stabilizing substituent (Lumera-legacy)
- US 9,703,128 — IC w/ optical data communication (BrPhotonics-origin)
- US 9,837,794 — Optoelectronic devices (Queen Mary U-assigned, NOT Chromosol)
- US 10,591,755 — Direct-drive polymer modulator
- US 12,187,827 — Crosslinkable NLO chromophore system (UW/NLM)
- US 11,634,429 — Organic EO chromophores (UW/NLM BAH13)
- US 10,571,724 — Electrooptic modulator (ETH ferroelectric plasmonic)
- US 11,764,873 — Wireless-to-optical antenna receiver (ETH)
Aggregator data
- GreyB Insights — Lightwave Logic patents (78 globally / 41 granted / 47 active)
- Minesoft via free-competitor-patent-data — LWLG 142 apps / 184 pubs / 52 grants / 47 families (last 10y) — counts include jurisdictional counterparts
- HyperLight Corporation patents page (~163 filings)
- Lightwave Logic patent portfolio page (corporate self-summary, “70+ U.S. and international patents”)
Press releases / corporate disclosures
- Marvell announcing Polariton acquisition (Apr 22, 2026)
- Marvell announcing 1.6T optical DSP portfolio (2025)
- LWLG diamondoid patent press release (Apr 1, 2024)
- LWLG ALD sealant patent press release (Jan 3, 2023)
- LWLG Chromosol acquisition press release (Nov 29, 2022)
- NLM thermoset patent press release (Mar 4, 2025)
- NLM Selerion-BHX record-r33 announcement (Jun 4, 2025)
- UW CoMotion-NLM exclusive license press release
Methodology notes
- All patent dates and claim language verified by direct fetch from Google Patents or USPTO record.
- Aggregator counts (GreyB, Minesoft) used for portfolio-size estimates only; cross-checked against corporate self-disclosure (LWLG “70+” / NLM “exclusive license to portfolio of patents” / HyperLight ~163).
- Forward-citation counts from Google Patents “Cited by” section; recent issues (post-2023) may show low citation counts simply due to recency.
- Expiration dates calculated as priority date + 20 years + patent-term adjustment (PTA) where shown on Google Patents legal-status section. PTA is shown patent-by-patent.
- All ”⚠” flags indicate items requiring follow-on direct USPTO PAIR query, law-firm FTO analysis, or specialist patent-search firm engagement.
- Litigation-probability assessments (§7) are analyst judgments, not legal opinions; calibration based on standard tech-IP collision-risk frameworks (probability of formal action over 24-month window given current public state).
End of patent landscape analysis. Companion file _agent_outputs/tech_patents_papers.md retains the prior-baseline patent stack notes; this file supersedes for analyst-grade FTO and continuation-strategy context.